Novavax Awarded $1.6 Billion From Operation Warp Speed to Fund COVID-19 Vaccine Program
The funds will support the rapid development and mass production of the biotech's coronavirus vaccine candidate, NVX-CoV2373.
Full Article
Novavax Awarded $1.6 Billion From Operation Warp Speed to Fund COVID-19 Vaccine Program
Motley Fool
0 shares
1 views
You might like
Related news coverage
Is Coronavirus Vaccine Made From Fetal Cell Lines?
Eurasia Review
By Matt Hadro
As coronavirus vaccine prototypes move closer to testing and approval, some Catholics are debating the..
-
US sinks another $2.1 billion into a potential vaccine
SeattlePI.com
-
U.S. Reaches $2.1 Billion Deal With Sanofi and GlaxoSmithKline For Coronavirus Vaccine
NPR
-
GlaxoSmithKline, Sanofi get $2.1B to fund Covid-19 vaccine under Operation Warp Speed
bizjournals
-
Is the coronavirus vaccine made from fetal cell lines?
CNA
Advertisement
More coverage
Why Are We Ignoring The Coming Autism Avalanche? – OpEd
Eurasia Review
By Pennel Bird*
Back in the year 2000 at the dawn of the new millennium, as Y2K fears faded to thin transparencies in..
Pfizer sales take a hit during pandemic
SeattlePI.com